Eosinophil Migration in Atopic Dermatitis I: Increased Migratory Responses to N-Formyl-Methionyl-Leucyl-Phenylalanine, Neutrophil-Activating Factor, Platelet-Activating Factor, and Platelet Factor 4

This publication has 28 references indexed in Scilit:

• Eosinophils altered phenotypically and primed by culture with granulocyte/macrophage colony-stimulating factor and 3T3 fibroblasts generate leukotriene C4 in response to FMLP.
  Journal of Clinical Investigation, 1991
• Characteristics of CR3-mediated aggregation in human eosinophils: Effect of priming by platelet-activating factor
  Journal of Allergy and Clinical Immunology, 1991
• Eosinophil cationic protein in sera of patients with atopic dermatitis
  Journal of the American Academy of Dermatology, 1991
• Human eosinophils have prolonged survival, enhanced functional properties, and become hypodense when exposed to human interleukin 3.
  Journal of Clinical Investigation, 1988
• Active participation of eosinophils in patch test reactions to inhalant allergens in patients with atopic dermatitis
  British Journal of Dermatology, 1988
• The regulation of human eosinophil function by cytokines
  Immunology Today, 1987
• Regulation of human eosinophil viability, density, and function by granulocyte/macrophage colony-stimulating factor in the presence of 3T3 fibroblasts.
  The Journal of Experimental Medicine, 1987
• Platelet-activating factor. A potent chemotactic and chemokinetic factor for human eosinophils.
  Journal of Clinical Investigation, 1986
• Eczematous reactions in atopic patients caused by epicutaneous testing with inhalant allergens
  British Journal of Dermatology, 1986
• Dermal Deposition of Eosinophil-Granule Major Basic Protein in Atopic Dermatitis
  New England Journal of Medicine, 1985